We are monitoring the impact of COVID-19 on APAC Testosterone Replacement Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4422
Share on
Share on

APAC Testosterone Replacement Therapy Market Research Report – Segmented By Product Type, Active Ingredient and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4422
Pages: 145

The size of the Testosterone Replacement Therapy Market in the Asia Pacific is estimated to witness a prominent CAGR from 2021 to 2026.

An increase in the frequency of testosterone insufficiency, an increase in the geriatric population at high risk of testosterone shortage, and increasing knowledge about testosterone substitution therapy are driving the Asia pacific testosterone replacement therapy market. In addition, the rising incidence of testosterone deficiency and Hormonal imbalance ailments, such as menopause, are likely to boost the Asia Pacific testosterone replacement treatment market.

The use of testosterone replacement therapy is on the rise, which is propelling the market forward. Furthermore, the market is being pushed by an aging population, which increases the danger of testosterone insufficiency. Hypogonadism affects more than 20.7 percent of diabetic patients globally, according to a study published in the Indian Journal of Endocrinology and Metabolism, especially those aged 40 to 79.

Hypogonadism is a hormonal imbalance in which the body cannot create enough testosterone. Topical testosterone is a medicine applied to the skin to treat the ailment. Topically applied testosterone medicine formulations include creams, gels, and patches.

Increased awareness of testosterone substitution therapy is propelling the Testosterone Replacement Therapy market in the Asia Pacific. In addition, the Endocrine Society established clinical practice recommendations on testosterone therapy to raise awareness of hypogonadism among medical practitioners. These factors are driving the market in the Asia Pacific region.

However, the Asia pacific testosterone replacement therapy market's growth pace is slowed by side effects connected with testosterone replacement therapies. Furthermore, market expansion in emerging countries is hampered by a lack of public awareness and infrastructure. The FDA's tight guidelines governing the use of testosterone medicines are stifling market expansion.

Because coronavirus spreads quickly through human-to-human contact, countries across APAC have implemented lockdowns. The Asian Pacific economy has been severely harmed due to the shutdown. Due to declining estrogen levels, older women are at a higher risk of disease. Furthermore, the absence of hormones may hasten the virus's spread throughout the body. The countries concentrated on primary services, ignoring all non-essential medical services, causing the market to stall. During the epidemic, the market is being hampered by a shortage of hospital facilities.

This research report on the APAC TRT market has been segmented & sub-segmented into the following categories:

By Product Type:

  • Patches    
  • Injections
  • Adhesives               
  • Implants  
  • Oral        

By Active Ingredient:

  • Testosterone Undecanoate            
  • Testosterone Enanthate   
  • Testosterone Cypionate   
  • Methyl Testosterone        

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Asia-Pacific is the third-largest market for testosterone replacement therapy in terms of revenue. Testosterone Replacement Therapy is becoming more common in emerging countries due to its large populations and increased awareness. The Asia Pacific is expected to develop at the fastest rate throughout the forecast period due to a large population and changing lifestyles. The Hormone Replacement Therapy Guidelines of the Japan Society of Obstetrics and Gynaecology and the Japan Society for Menopause and Women's Health were amended in 2012. People were asked about their thoughts on HRT to feel more at ease with the procedure.

In Indonesia, hormones such as testosterone, oestradiol, estrogen, estriol, and progesterone are utilized in bioidentical hormone replacement therapy. Indonesia's market growth is expected to be boosted by the availability of HRT centers in the country. Androgen is the most common testosterone treatment medicine, according to an article. Healthcare professionals' growing awareness and increased attention on removing hormonal shortages are expected to drive market expansion in nations like Malaysia, Bangladesh, and Bhutan. In addition, the increased demand for hormone replacement therapy to treat dwarfism and innovations in drug delivery technology and postmenopausal diseases in women are helping these countries grow their markets.

KEY MARKET PLAYERS:

Companies playing a vital role in the APAC Testosterone Replacement Therapy market covered in this report are Pfizer Inc., Allergan Plc., AbbVie Inc., Bayer AG., Eli Lilly and Company, Endo Pharmaceuticals, Kyowa Kirin International Plc., Novartis AG. and Mylan N.V. among others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Patches    

                                5.1.2 Injections

                                5.1.3 Adhesives               

                                5.1.4 Implants   

                                5.1.5 Oral            

                                5.1.6  Y-o-Y Growth Analysis, By Product Type   

                                5.1.7  Market Attractiveness Analysis, By Product Type                 

                                5.1.8  Market Share Analysis, By Product Type   

                5.2 Active Ingredient                     

                                5.2.1 Testosterone Undecanoate            

                                5.2.2 Testosterone Enanthate   

                                5.2.3 Testosterone Cypionate   

                                5.2.4 Methyl Testosterone         

                                5.2.5 Active Ingredient                 

                                5.2.6 Y-o-Y Growth Analysis, By Active Ingredient            

                                5.2.7 Market Attractiveness Analysis, By Active Ingredient          

                                5.2.8 Market Share Analysis, By Active Ingredient            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Product Type

                                                6.1.3.2 By Active Ingredient

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Product Type

                                                6.1.4.2 By Active Ingredient

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Product Type

                                                6.1.5.2 By Active Ingredient

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Allergan Plc.                               

                8.3 AbbVie Inc.                 

                8.4 Bayer AG.                    

                8.5 Eli Lilly and Company                              

                8.6 Endo Pharmaceuticals                            

                8.7 Kyowa Kirin International Plc.                             

                8.8 Novartis AG.                              

                8.9 Mylan N.V.                 

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Asia Pacific Testosterone Replacement Therapy Market, By Product Type, From 2021 to 2026 (USD Million)
  2. Asia Pacific Patches Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Injections Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific Adhesives Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia Pacific Implants  Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia Pacific Oral Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia Pacific Testosterone Replacement Therapy Market, By Active Ingredient, From 2021 to 2026 (USD Million)
  8. Asia Pacific Testosterone Undecanoate Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia Pacific Testosterone Enanthate Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia Pacific Testosterone Cypionate Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia Pacific Methyl Testosterone  Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia Pacific Testosterone Market, By Region, From 2021 to 2026 (USD Million)
  13. Japan Testosterone Replacement Therapy Market, By Product Type, From 2021 to 2026 (USD Million)
  14. Japan Testosterone Replacement Therapy Market, By Active Ingredient, From 2021 to 2026 (USD Million)
  15. China Testosterone Replacement Therapy Market, By Product Type, From 2021 to 2026 (USD Million)
  16. China Testosterone Replacement Therapy Market, By Active Ingredient, From 2021 to 2026 (USD Million)
  17. India Testosterone Replacement Therapy Market, By Product Type, From 2021 to 2026 (USD Million)
  18. India Testosterone Replacement Therapy Market, By Active Ingredient, From 2021 to 2026 (USD Million)
  19. Australia Testosterone Replacement Therapy Market, By Product Type, From 2021 to 2026 (USD Million)
  20. Australia Testosterone Replacement Therapy Market, By Active Ingredient, From 2021 to 2026 (USD Million)
  21. South Korea Testosterone Replacement Therapy Market, By Product Type, From 2021 to 2026 (USD Million)
  22. South Korea Testosterone Replacement Therapy Market, By Active Ingredient, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample